Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: a retrospective chart review (Q34147258)

31 July 2017

title

Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: a retrospective chart review (English)

1 reference

31 July 2017

main subject

botulinum toxin type A

1 reference

1 reference

Brashear A

1 reference

31 July 2017

Watts MW

1 reference

31 July 2017

Marchetti A

1 reference

31 July 2017

Magar R

1 reference

31 July 2017

Lau H

1 reference

31 July 2017

Wang L

1 reference

31 July 2017

publication date

1 December 2000

1 reference

31 July 2017

published in

Clinical Therapeutics

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

1516-1524

1 reference

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

Modification of muscle activity after BOTOX injections in spasmodic torticollis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

A pilot study on the use of botulinum toxin in spasmodic torticollis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2983049-0

7 January 2021

10.1016/S0149-2918(00)83049-0

Identifiers

DOI

1 reference

31 July 2017

1 reference